Cargando…
The authors' response: Propofol in COVID 19: From basic science to clinical impact()
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Inc.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7347304/ https://www.ncbi.nlm.nih.gov/pubmed/32690223 http://dx.doi.org/10.1016/j.ajem.2020.07.006 |
| _version_ | 1783556564218544128 |
|---|---|
| author | Soh, Mitsuhito Hifumi, Toru Isokawa, Shutaro Shimizu, Masato Otani, Norio Ishimatsu, Shinichi |
| author_facet | Soh, Mitsuhito Hifumi, Toru Isokawa, Shutaro Shimizu, Masato Otani, Norio Ishimatsu, Shinichi |
| author_sort | Soh, Mitsuhito |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7347304 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Elsevier Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-73473042020-07-10 The authors' response: Propofol in COVID 19: From basic science to clinical impact() Soh, Mitsuhito Hifumi, Toru Isokawa, Shutaro Shimizu, Masato Otani, Norio Ishimatsu, Shinichi Am J Emerg Med Article Elsevier Inc. 2021-07 2020-07-09 /pmc/articles/PMC7347304/ /pubmed/32690223 http://dx.doi.org/10.1016/j.ajem.2020.07.006 Text en © 2020 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Article Soh, Mitsuhito Hifumi, Toru Isokawa, Shutaro Shimizu, Masato Otani, Norio Ishimatsu, Shinichi The authors' response: Propofol in COVID 19: From basic science to clinical impact() |
| title | The authors' response: Propofol in COVID 19: From basic science to clinical impact() |
| title_full | The authors' response: Propofol in COVID 19: From basic science to clinical impact() |
| title_fullStr | The authors' response: Propofol in COVID 19: From basic science to clinical impact() |
| title_full_unstemmed | The authors' response: Propofol in COVID 19: From basic science to clinical impact() |
| title_short | The authors' response: Propofol in COVID 19: From basic science to clinical impact() |
| title_sort | authors' response: propofol in covid 19: from basic science to clinical impact() |
| topic | Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7347304/ https://www.ncbi.nlm.nih.gov/pubmed/32690223 http://dx.doi.org/10.1016/j.ajem.2020.07.006 |
| work_keys_str_mv | AT sohmitsuhito theauthorsresponsepropofolincovid19frombasicsciencetoclinicalimpact AT hifumitoru theauthorsresponsepropofolincovid19frombasicsciencetoclinicalimpact AT isokawashutaro theauthorsresponsepropofolincovid19frombasicsciencetoclinicalimpact AT shimizumasato theauthorsresponsepropofolincovid19frombasicsciencetoclinicalimpact AT otaninorio theauthorsresponsepropofolincovid19frombasicsciencetoclinicalimpact AT ishimatsushinichi theauthorsresponsepropofolincovid19frombasicsciencetoclinicalimpact AT sohmitsuhito authorsresponsepropofolincovid19frombasicsciencetoclinicalimpact AT hifumitoru authorsresponsepropofolincovid19frombasicsciencetoclinicalimpact AT isokawashutaro authorsresponsepropofolincovid19frombasicsciencetoclinicalimpact AT shimizumasato authorsresponsepropofolincovid19frombasicsciencetoclinicalimpact AT otaninorio authorsresponsepropofolincovid19frombasicsciencetoclinicalimpact AT ishimatsushinichi authorsresponsepropofolincovid19frombasicsciencetoclinicalimpact |